Goyang-si, South Korea

Kyung Sil Yoon

This inventor holds 1 USPTO granted patent. Top assignees: National Cancer Center, National Institute for Korean Medicine Development. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyung Sil Yoon. Retrieved from https://idiyas.com/inventor/kyung-sil-yoon-h66xcf7f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kyung Sil Yoon: Innovator in Lung Cancer Treatment

Introduction

Kyung Sil Yoon is a notable inventor based in Goyang-si, South Korea. He has made significant contributions to the field of medicine, particularly in the area of cancer treatment. His innovative work has led to the development of a patent that addresses a critical health issue.

Latest Patents

Kyung Sil Yoon holds a patent for a "Composition for Preventing or Treating Lung Cancer, Comprising a Compound Isolated from Cephalotaxus Extract as an Active Ingredient." This patent highlights his commitment to finding effective solutions for lung cancer, a disease that affects millions worldwide. He has 1 patent to his name, showcasing his innovative approach to medical research.

Career Highlights

Throughout his career, Kyung Sil Yoon has worked with esteemed organizations such as the National Cancer Center and the National Institute for Korean Medicine Development. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Kyung Sil Yoon has collaborated with notable colleagues, including Yong Nyun Kim and Jae Gal Shim. These partnerships have further enhanced his research and development efforts in cancer treatment.

Conclusion

Kyung Sil Yoon's work in developing a composition for lung cancer treatment exemplifies his dedication to medical innovation. His contributions are vital in the ongoing fight against cancer, and his patent reflects the potential for new therapeutic approaches.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…